Waters Corporation Stock Berne S.E.

Equities

WAZ

US9418481035

Advanced Medical Equipment & Technology

Market Closed - Berne S.E. 5-day change 1st Jan Change
- CHF -.--% Intraday chart for Waters Corporation -.--% -.--%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2024 * 2.97B 2.69B Sales 2025 * 3.15B 2.85B Capitalization 20.83B 18.87B
Net income 2024 * 637M 577M Net income 2025 * 719M 651M EV / Sales 2024 * 7.46 x
Net Debt 2024 * 1.31B 1.19B Net Debt 2025 * 1.1B 994M EV / Sales 2025 * 6.96 x
P/E ratio 2024 *
32.5 x
P/E ratio 2025 *
28.6 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 36.4%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 53 20-08-31
Director of Finance/CFO 48 21-05-11
Chief Operating Officer - 21-12-31
Members of the board TitleAgeSince
Director/Board Member 65 18-08-31
Director/Board Member 68 23-03-26
Director/Board Member 70 06-04-30
More insiders
Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
351.1 USD
Average target price
324.4 USD
Spread / Average Target
-7.61%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW